Dr. Edwin Gomez, MD
Claim this profileCenExel RCA
Affiliated Hospitals
CenExel RCA
More about Edwin Gomez, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Edwin Gomez, MD has experience with
- LB-102
Breakdown of trials Edwin Gomez, MD has run
Schizophrenia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Edwin Gomez, MD specialize in?
Edwin Gomez, MD focuses on Schizophrenia and other conditions. In particular, much of their work with Schizophrenia has involved treating patients, or patients who are undergoing treatment.
Is Edwin Gomez, MD currently recruiting for clinical trials?
No, Edwin Gomez, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Edwin Gomez, MD has studied deeply?
Yes, Edwin Gomez, MD has studied treatments such as LB-102.
What is the best way to schedule an appointment with Edwin Gomez, MD?
Apply for one of the trials that Edwin Gomez, MD is conducting.
What is the office address of Edwin Gomez, MD?
The office of Edwin Gomez, MD is located at: CenExel RCA, Hollywood, Florida 33024 United States. This is the address for their practice at the CenExel RCA.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.